NCT05522959 Cardio-Oncology Rehabilitation Exercise
| NCT ID | NCT05522959 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Toronto |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2022-03-14 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2022-03-14 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Women with breast cancer who are referred to the cardiac rehabilitation program at the Toronto Rehabilitation Institute will be invited to enrol in this observational study. Participants will take part in an established 16-week multimodal cardiac rehabilitation program (HEALTh program) at Toronto Rehabilitation Institute and outcome measures will be assessed before and after program participation to determine the effectiveness of the program in improving cardio metabolic health. Change in VO₂peak will be assessed using Cardiopulmonary Exercise Test (CPET). Traditional cardiac risk factors, lifestyle behaviours, exercise adherence, health-related quality of life, and fatigue will also be assessed.
Eligibility Criteria
Inclusion Criteria: * History of early-stage breast cancer (I-III) * Currently receiving or have completed adjuvant therapy (i.e. chemotherapy, surgery, radiation, targeted therapies) * Able to communicate in English Exclusion Criteria: * Pregnancy * Metastatic disease (Stage IV) * Unable or unwilling to complete cardiopulmonary exercise test
Contact & Investigator
Amy Kirkham, PhD
PRINCIPAL INVESTIGATOR
University of Toronto
Frequently Asked Questions
Who can join the NCT05522959 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05522959 currently recruiting?
Yes, NCT05522959 is actively recruiting participants. Contact the research team at amy.kirkham@utoronto.ca for enrollment information.
Where is the NCT05522959 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT05522959 clinical trial?
NCT05522959 is sponsored by University of Toronto. The principal investigator is Amy Kirkham, PhD at University of Toronto. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.